Insider Transaction Report for Ascendis Pharma A/S

Mads Bodenhoff, SVP & PAO of Ascendis Pharma A/S, reported a series of transactions on September 8, 2026. Bodenhoff acquired 3,000 ordinary shares at a price of $110.00 per share. Subsequently, Bodenhoff disposed of 3,000 ordinary shares at a price of $270.19 per share, resulting in zero shares held. Additionally, Bodenhoff disposed of 3,000 warrants with a strike price of $110.00, leaving 687 warrants outstanding. These warrants vest in installments, with 25% vesting on October 11, 2023, and the remainder vesting monthly over 36 months. The reporting signature date was September 10, 2026.